![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Prostate Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Artificial Intelligence (AI) for Automated Cancer Detection on Prostate MRI:
Opportunities and Ongoing Challenges, From the AJR Special Series on AI
Applications.
AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.26917.
PubMed
Abstract available
Active surveillance versus enzalutamide for low-risk prostate cancer- was it
really a trial we needed?
BJU Int. 2022 Jul 25. doi: 10.1111/bju.15860.
PubMed
Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and
poor clinical outcome in prostate cancer.
Br J Cancer. 2022 Jul 22. pii: 10.1038/s41416-022-01914.
PubMed
Abstract available
The potential of a nomogram combined PI-RADS v2.1 and contrast-enhanced
ultrasound (CEUS) to reduce unnecessary biopsies in prostate cancer diagnostics.
Br J Radiol. 2022 Jul 25:20220209. doi: 10.1259/bjr.20220209.
PubMed
Abstract available
Gross tumor volume delineation in primary prostate cancer on (18)F-PSMA-1007
PET/MRI and (68)Ga-PSMA-11 PET/MRI.
Cancer Imaging. 2022;22:36.
PubMed
Abstract available
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases
in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical
Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned
Interim Analysis of a
Eur Urol. 2022 Jul 22. pii: S0302-2838(22)02417.
PubMed
Abstract available
Somatic mutations reveal complex metastatic seeding from multifocal primary
prostate cancer.
Int J Cancer. 2022 Jul 26. doi: 10.1002/ijc.34226.
PubMed
Abstract available
Radiotherapy in Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2022 Jul 22. pii: S0360-3016(22)00732.
PubMed
Abstract available
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical
Prostatectomy for Locally Advanced Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2022 Jul 22. pii: S0360-3016(22)00736.
PubMed
Abstract available
Common iliac node positive prostate cancer treated with curative radiotherapy: N1
or M1a?
Int J Radiat Oncol Biol Phys. 2022 Jul 20. pii: S0360-3016(22)00731.
PubMed
Abstract available
Evaluation of (11) C-choline positron emission tomography/computed tomography for
determining treatment response in castration-resistant prostate cancer patients.
Int J Urol. 2022 Jul 25. doi: 10.1111/iju.14992.
PubMed
Abstract available
RE: Grade Migration of Prostate Cancer in the United States during the last
decade.
J Natl Cancer Inst. 2022 Jul 26. pii: 6650145. doi: 10.1093.
PubMed
Impact of Left-digit Age Bias in the Treatment of Localized Prostate Cancer.
J Urol. 2022 Jul 28:101097JU0000000000002857. doi: 10.1097/JU.0000000000002857.
PubMed
Abstract available
Analysis of separate training and validation radical prostatectomy cohorts
identifies 0.25 mm diameter as an optimal definition for "large" cribriform
prostatic adenocarcinoma.
Mod Pathol. 2022;35:1092-1100.
PubMed
Abstract available
The unclear role of PET-CT in localized radiorecurrent prostate cancer.
Nat Rev Urol. 2022 Jul 25. pii: 10.1038/s41585-022-00635.
PubMed
"I always find myself very tired and exhausted": The physical impact of caring; a
descriptive phenomenological study of the experiences of prostate cancer
caregivers in Cape Coast, Ghana.
PLoS One. 2022;17:e0268627.
PubMed
Abstract available
An update on the current status and future prospects of erectile dysfunction
following radical prostatectomy.
Prostate. 2022 May 17. doi: 10.1002/pros.24366.
PubMed
Abstract available
Using health insurance claims data to assess long-term disease progression in a
prostate cancer cohort.
Prostate. 2022 Jul 26. doi: 10.1002/pros.24418.
PubMed
Abstract available
Prognostic role of pan-immune-inflammation value in patients with metastatic
castration-resistant prostate cancer treated with androgen receptor-signaling
inhibitors.
Prostate. 2022 Jul 28. doi: 10.1002/pros.24419.
PubMed
Abstract available
Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate
Cancer with Multiparametric versus Hybrid Multidimensional MRI.
Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
PubMed
Abstract available
Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for
Recurrence Reporting Assessment Score.
Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
PubMed
Abstract available
Role of multi-parametric magnetic resonance imaging fusion biopsy in active
surveillance of prostate cancer: a systematic review.
Ther Adv Urol. 2022;14:17562872221106883.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by